BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12109355)

  • 1. Green tea and prostate cancer.
    Gupta S; Mukhtar H
    Urol Clin North Am; 2002 Feb; 29(1):49-57, viii. PubMed ID: 12109355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer chemoprevention by green tea.
    Gupta S; Ahmad N; Mukhtar H
    Semin Urol Oncol; 1999 May; 17(2):70-6. PubMed ID: 10332919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into the mechanisms of green tea catechins in the chemoprevention of prostate cancer.
    Connors SK; Chornokur G; Kumar NB
    Nutr Cancer; 2012; 64(1):4-22. PubMed ID: 22098273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular targets for green tea in prostate cancer prevention.
    Adhami VM; Ahmad N; Mukhtar H
    J Nutr; 2003 Jul; 133(7 Suppl):2417S-2424S. PubMed ID: 12840218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tea beverage in chemoprevention of prostate cancer: a mini-review.
    Saleem M; Adhami VM; Siddiqui IA; Mukhtar H
    Nutr Cancer; 2003; 47(1):13-23. PubMed ID: 14769533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Green tea catechins for chemoprevention of prostate cancer in patients with histologically-proven HG-PIN or ASAP. Concise review and meta-analysis.
    Perletti G; Magri V; Vral A; Stamatiou K; Trinchieri A
    Arch Ital Urol Androl; 2019 Oct; 91(3):. PubMed ID: 31577096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer chemoprevention with green tea catechins by targeting receptor tyrosine kinases.
    Shimizu M; Adachi S; Masuda M; Kozawa O; Moriwaki H
    Mol Nutr Food Res; 2011 Jun; 55(6):832-43. PubMed ID: 21538846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study.
    Bettuzzi S; Brausi M; Rizzi F; Castagnetti G; Peracchia G; Corti A
    Cancer Res; 2006 Jan; 66(2):1234-40. PubMed ID: 16424063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of CWR22Rnu1 tumor growth and PSA secretion in athymic nude mice by green and black teas.
    Siddiqui IA; Zaman N; Aziz MH; Reagan-Shaw SR; Sarfaraz S; Adhami VM; Ahmad N; Raisuddin S; Mukhtar H
    Carcinogenesis; 2006 Apr; 27(4):833-9. PubMed ID: 16387739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relevance of the inhibitory effect of green tea catechins (GtCs) on prostate cancer progression in combination with molecular profiling of catechin-resistant tumors: an integrated view.
    Bettuzzi S; Rizzi F; Belloni L
    Pol J Vet Sci; 2007; 10(1):57-60. PubMed ID: 17388027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Green Tea Consumption on Prostate Cancer Risk and Progression: A Systematic Review.
    Jacob SA; Khan TM; Lee LH
    Nutr Cancer; 2017 Apr; 69(3):353-364. PubMed ID: 28287319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Green tea polyphenols and cancer chemoprevention of genitourinary cancer.
    Bailey HH; Mukhtar H
    Am Soc Clin Oncol Educ Book; 2013; ():92-6. PubMed ID: 23714466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoprevention of human prostate cancer by green tea catechins: two years later. A follow-up update.
    Brausi M; Rizzi F; Bettuzzi S
    Eur Urol; 2008 Aug; 54(2):472-3. PubMed ID: 18406041
    [No Abstract]   [Full Text] [Related]  

  • 14. The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression.
    Caporali A; Davalli P; Astancolle S; D'Arca D; Brausi M; Bettuzzi S; Corti A
    Carcinogenesis; 2004 Nov; 25(11):2217-24. PubMed ID: 15358631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Green tea and the risk of prostate cancer: A systematic review and meta-analysis.
    Guo Y; Zhi F; Chen P; Zhao K; Xiang H; Mao Q; Wang X; Zhang X
    Medicine (Baltimore); 2017 Mar; 96(13):e6426. PubMed ID: 28353571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigallocatechin-3-Gallate suppresses early stage, but not late stage prostate cancer in TRAMP mice: mechanisms of action.
    Harper CE; Patel BB; Wang J; Eltoum IA; Lamartiniere CA
    Prostate; 2007 Oct; 67(14):1576-89. PubMed ID: 17705241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of catechin extracts and nanoemulsions from green tea leaf waste and their inhibition effect on prostate cancer cell PC-3.
    Tsai YJ; Chen BH
    Int J Nanomedicine; 2016; 11():1907-26. PubMed ID: 27226712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer chemoprevention with green tea catechins: from bench to bed.
    Shirakami Y; Shimizu M; Moriwaki H
    Curr Drug Targets; 2012 Dec; 13(14):1842-57. PubMed ID: 23140294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGCG suppresses prostate cancer cell growth modulating acetylation of androgen receptor by anti-histone acetyltransferase activity.
    Lee YH; Kwak J; Choi HK; Choi KC; Kim S; Lee J; Jun W; Park HJ; Yoon HG
    Int J Mol Med; 2012 Jul; 30(1):69-74. PubMed ID: 22505206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soy phytochemicals and tea bioactive components synergistically inhibit androgen-sensitive human prostate tumors in mice.
    Zhou JR; Yu L; Zhong Y; Blackburn GL
    J Nutr; 2003 Feb; 133(2):516-21. PubMed ID: 12566493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.